Plunkett Research Online: OncoMed Pharmaceuticals Inc

ONCOMED PHARMACEUTICALS INC (OMED:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

OncoMed Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics that address the fundamental biology driving cancer’s growth, resistance, recurrence, and metastasis. The company's therapeutic candidates and preclinical programs inclu.....



OncoMed Pharmaceuticals Inc
Ticker: OMED
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 995-8200
Fax: 650 995-8600
Address: 800 Chesapeake Drive
Redwood City, CA 94063 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
John LewickiCEO/President
Yvonne LiCFO/Chief Accounting Officer
See More
OncoMed Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics that address the fundamental biology driving cancer’s growth, resistance, recurrence, and metastasis. The company's therapeutic candidates and preclinical programs inclu.....See More See More

Auditor: ERNST & YOUNG, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: